Makaleler
Tümü (5)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (5)
Scopus (5)
2023
20231. Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkish oncology group study
Acar R., PAYDAŞ S., Yildirim M., Kiliçarslan E., Sahin U., DOĞAN A., et al.
Journal of Cancer Research and Therapeutics
, cilt.19, sa.8, 2023 (SCI-Expanded, Scopus)
2015
20152. Potassium Abnormalities in Current Clinical Practice: Frequency, Causes, Severity and Management
Eliacik E., YILDIRIM T., Sahin U., Kizilarslanoglu C., Tapan U., Aybal-Kutlugun A., et al.
MEDICAL PRINCIPLES AND PRACTICE
, cilt.24, sa.3, ss.271-275, 2015 (SCI-Expanded, Scopus)
2013
20133. Association of breast cancer subtypes and body mass index
Petekkaya I., ŞAHİN U., Gezgen G., Solak M., YÜCE D., DİZDAR Ö., et al.
TUMORI J
, cilt.99, sa.2, ss.129-133, 2013 (SCI-Expanded, Scopus)
2012
20124. Prognosis of breast cancer in patients with peritoneal metastasis
Petekkaya I., Ayyildiz V., KIZILARSLANOĞLU M. C., ŞAHİN U., Gezgen G., Roach E. C., et al.
BREAST
, cilt.21, sa.3, ss.420-421, 2012 (SCI-Expanded, Scopus)
2010
20105. Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?
Alkan A., ŞAHİN U., Altundag K.
MEDICAL ONCOLOGY
, cilt.27, sa.4, ss.1430, 2010 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2013
20131. Association of the neutrophil to lymphocyte ratio with survival patients with in metastatic breast cancer.
Unlu O., Aygun S., Petekkaya H., Gecmez G., Roach E. C., Babacan T., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
20132. Early stage "T2N0" breast cancer: Does it consist two different "T2" stages?
Arslan C., Sahin U., Kizilarslanoglu C., Solak M., Gullu I. H., Ozisik Y., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
20133. Inflammatory markers in early-stage breast cancer.
Petekkaya H., Aksoy S., Gecmez G., Kulahcioglu E., Okoh A. K., Isler D. C., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
20134. Inflammatory markers in metastatic breast cancer.
Sahin U., Petekkaya H., Gecmez G., Babacan T., Roach E. C., Sarici S. F., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2012
20125. Impact of obesity in postmenopausal early breast cancer patients receiving frontline adjuvant aromatase inhibitors.
Sahin U., Petekkaya I., Arslan C., Sarici S. F., Solak M., Keskin O., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
20126. Non-breast solid malignancies among breast cancer survivors
Altundag K., Petekkaya I., Sahin U., Solak M., Ozisik Y.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
20127. Prognosis of breast cancer in patients with peritoneal metastasis
Petekkaya I., Ayyildiz V., Kizilarslanoglu C., Sahin U., Gezgen G., Roach E. C., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)